Farnum Rhonda sold TBPH
December 3, 2025 · Form 4 insider transaction
Farnum Rhonda sold 7,766 shares of Theravance Biopharma, Inc. at $18.75 per share, a transaction worth $145.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,766
Price
$18.75
Total value
$145.6K
InsiderFarnum Rhonda
RoleOfficer
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateDecember 3, 2025
Filing dateDecember 5, 2025
Shares owned after293,229
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.